CC BY-NC-ND 4.0 · Asian J Neurosurg 2014; 9(04): 182-188
DOI: 10.4103/1793-5482.146597
ORIGINAL ARTICLE

Role of sertraline in posttraumatic brain injury depression and quality-of-life in TBI

Ahmed Ansari
Department of Neurosurgery, S.M.S. Medical College, Jaipur, Rajasthan
,
Akhilesh Jain
1   Department of Psychiatry, ESIC Model Hospital, Jaipur, Rajasthan
,
Achal Sharma
Department of Neurosurgery, S.M.S. Medical College, Jaipur, Rajasthan
,
R Mittal
Department of Neurosurgery, S.M.S. Medical College, Jaipur, Rajasthan
,
I Gupta
2   Department of Psychiatry, S.M.S Medical College, Jaipur, Rajasthan
› Author Affiliations

Introduction: Traumatic brain injury (TBI) is a major cause of disability. Depression is one of the major squeal of TBI in both in-patient and out-patient populations. Depression is associated with numerous negative outcomes, thus affecting quality-of-life (QOL) adversely in these patients. Addressing depression in treatment regimen of TBI may improve QOL of these patients. Objective: The present study is designed to evaluate the role of sertraline in post TBI depression and its impact on QOL. Materials and Methods: Eighty male patients with post TBI depression were included in the study among the 250 male patients of mild to moderate TBI recruited for the evaluation. Half of the patients were given sertraline 50 mg PO, whereas other half served as control without sertraline treatment. Participants were assessed on Glasgow Coma scale, Patient Health Questionnaire-9 (PHQ-9) and World Health Organization QOL (WHOQOL) at regular interval till the end of 6 months. Result: Depression was found in 35.6% of total patients recruited. Most of the patients (63.1%) were below 35 years of age. Depression was more common in mild TBI cases than those with moderate TBI (53.7% vs. 46.25%, P = 0.04). Left side brain injury (56.25%) with cerebral contusions was more commonly associated with depression (P = 0.04). Patients in sertraline group responded well to treatment with significant improvement in mod symptoms (PHQ-9 score 14.88 ± 3.603 vs. 5.33 ± 2.98, P = 0.04)). All the four domains of QOL improved significantly in sertraline group than the control group with sertraline treatment. Conclusion: Management of TBI should also focus on treatment of associated mood symptoms, which is likely to be associated with poor QOL in these patients. Sertraline has been found to be effective in the treatment of depression with significant improvement in QOL in TBI patients.



Publication History

Article published online:
22 September 2022

© 2014. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India